Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Vir Biotechnology stock

Learn how to easily invest in Vir Biotechnology stock.

Vir Biotechnology Inc is a biotechnology business based in the US. Vir Biotechnology shares (VIR) are listed on the NASDAQ and all prices are listed in US Dollars. Vir Biotechnology employs 444 staff and has a trailing 12-month revenue of around $2.1 billion.

How to buy shares in Vir Biotechnology

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VIR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Vir Biotechnology stock price (NASDAQ: VIR)

Use our graph to track the performance of VIR stocks over time.

Vir Biotechnology shares at a glance

Information last updated 2022-09-27.
Latest market close$19.28
52-week range$18.05 - $58.00
50-day moving average $25.23
200-day moving average $27.77
Wall St. target price$48.25
PE ratio 2.2768
Dividend yield $0 (0%)
Earnings per share (TTM) $8.02

Buy Vir Biotechnology shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Vir Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vir Biotechnology price performance over time

Historical closes compared with the close of $19.28 from 2022-09-30

1 week (2022-09-23) 3.71%
1 month (2022-09-02) -18.65%
3 months (2022-07-01) -25.47%
6 months (2022-04-01) -23.79%
1 year (2021-10-01) -43.87%
2 years (2020-10-02) -42.15%
3 years (2019-09-28) N/A
5 years (2017-09-28) N/A

Is Vir Biotechnology stock undervalued or overvalued?

Valuing Vir Biotechnology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vir Biotechnology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Vir Biotechnology's P/E ratio

Vir Biotechnology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Vir Biotechnology shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Vir Biotechnology's EBITDA

Vir Biotechnology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.

The EBITDA is a measure of a Vir Biotechnology's overall financial performance and is widely used to measure a its profitability.

Vir Biotechnology financials

Revenue TTM $2.1 billion
Operating margin TTM 64.3%
Gross profit TTM $590.7 million
Return on assets TTM 46.09%
Return on equity TTM 80.15%
Profit margin 51.13%
Book value $14.72
Market capitalisation $2.4 billion

TTM: trailing 12 months

Vir Biotechnology share dividends

We're not expecting Vir Biotechnology to pay a dividend over the next 12 months.

Vir Biotechnology share price volatility

Over the last 12 months, Vir Biotechnology's shares have ranged in value from as little as $18.05 up to $58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vir Biotechnology's is -0.2947. This would suggest that Vir Biotechnology's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Vir Biotechnology has bucked the trend.

Vir Biotechnology overview

Vir Biotechnology, Inc. , a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. ; license agreements with The Rockefeller University and MedImmune, Inc. ; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd. ; and a collaborative research agreement with GlaxoSmithKline Biologicals SA.

Frequently asked questions

What percentage of Vir Biotechnology is owned by insiders or institutions?
Currently 13.611% of Vir Biotechnology shares are held by insiders and 76.316% by institutions.
How many people work for Vir Biotechnology?
Latest data suggests 444 work at Vir Biotechnology.
When does the fiscal year end for Vir Biotechnology?
Vir Biotechnology's fiscal year ends in December.
Where is Vir Biotechnology based?
Vir Biotechnology's address is: 499 Illinois Street, San Francisco, CA, United States, 94158
What is Vir Biotechnology's ISIN number?
Vir Biotechnology's international securities identification number is: US92764N1028
What is Vir Biotechnology's CUSIP number?
Vir Biotechnology's Committee on Uniform Securities Identification Procedures number is: 92764N102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site